Bruker Corp Q2 2023 Earnings Call Summary - Thomson StreetEvents

Bruker Corp Q2 2023 Earnings Call Summary

Bruker Corp Q2 2023 Earnings Call Summary - Thomson StreetEvents
Bruker Corp Q2 2023 Earnings Call Summary
Published Aug 03, 2023
17 pages (9726 words) — Published Aug 03, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of BRKR.OQ earnings conference call or presentation 3-Aug-23 12:30pm GMT

  
Brief Excerpt:

...A. In the second quarter of '23 we saw continued bookings growth from academia, government and academic medical centers and contra retail industry trends. B. We are pleased with our continued growth in bookings in biopharma as well as in China, both in the second quarter and in the first half of 2023. C. We expect solid mid-single digits to high single digit organic revenue growth in the second half of 2023. D. We will continue our strategic investments in our transformative Project Accelerate 2.0 particularly in proteomics and spatial biology, but also in recently acquired additional growth drivers in proteomics consumables, proteomics drug discovery services, neuroscience research tools, applied market solutions and scientific software. E. In the second quarter of 2023, Bruker delivered another solid quarter with organic revenue growth of 13.5% and non-GAAP EPS growth of 11.1% year-over-year. F. Bruker's second quarter '23 reported revenues increased 15.9% year-over-year to $681.9 million,...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Bruker Corp
Ticker
BRKR.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst : I wanted to follow up on Patrick's question earlier about China. So you mentioned that APAC growth was in the high 20s. Can you give us what was the specific China growth in the quarter? And then what did orders grow in China? And as a follow-up, what are you hearing on additional stimulus tranches being released in the region. We've heard from some of your peers that there could be some stimulus coming in 4Q. So what are your expectations there? And how is that contemplated in this year's guidance?

Question: Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst : Great. And then just one more for me. On back, you previously talked about growing throughout the year and the supply chain was really the limiting factor there rolling off. So can you talk about 18% growth this quarter was obviously pretty impressive. How is that supply chain factor kind of driving through those numbers? And then how should we think about that segment sequentially throughout the back half of the year?

Table Of Contents

Bruker Corp at Jefferies London Healthcare Conference Transcript – 2023-11-14 – US$ 54.00 – Edited Transcript of BRKR.OQ presentation 14-Nov-23 8:30am GMT

Bruker Corp Q3 2023 Earnings Call Summary – 2023-11-02 – US$ 54.00 – Edited Brief of BRKR.OQ earnings conference call or presentation 2-Nov-23 12:30pm GMT

Bruker Corp Q3 2023 Earnings Call Transcript – 2023-11-02 – US$ 54.00 – Edited Transcript of BRKR.OQ earnings conference call or presentation 2-Nov-23 12:30pm GMT

Bruker Corp at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-13 – US$ 54.00 – Edited Transcript of BRKR.OQ presentation 13-Sep-23 8:15pm GMT

Bruker Corp Q2 2023 Earnings Call Transcript – 2023-08-03 – US$ 54.00 – Edited Transcript of BRKR.OQ earnings conference call or presentation 3-Aug-23 12:30pm GMT

Bruker Corp To Host Investor Day Summary – 2023-06-15 – US$ 54.00 – Edited Brief of BRKR.OQ corporate analyst meeting</ 15-Jun-23 3:00pm GMT

Bruker Corp To Host Investor Day Transcript – 2023-06-15 – US$ 54.00 – Edited Transcript of BRKR.OQ corporate analyst meeting</ 15-Jun-23 3:00pm GMT

Bruker Corp at Jefferies Healthcare Conference Summary – 2023-06-09 – US$ 54.00 – Edited Brief of BRKR.OQ presentation 9-Jun-23 1:00pm GMT

Bruker Corp at Jefferies Healthcare Conference Transcript – 2023-06-09 – US$ 54.00 – Edited Transcript of BRKR.OQ presentation 9-Jun-23 1:00pm GMT

Bruker Corp Q1 2023 Earnings Call Summary – 2023-05-04 – US$ 54.00 – Edited Brief of BRKR.OQ earnings conference call or presentation 4-May-23 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Bruker Corp Q2 2023 Earnings Call Summary" Aug 03, 2023. Alacra Store. May 18, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Bruker-Corp-Earnings-Call-B15669621>
  
APA:
Thomson StreetEvents. (2023). Bruker Corp Q2 2023 Earnings Call Summary Aug 03, 2023. New York, NY: Alacra Store. Retrieved May 18, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Bruker-Corp-Earnings-Call-B15669621>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.